Dr. Wenyang Li and Dr. Yihui Gao from Prof. Xiaoguang Lei’s group participated in the EASL Congress 2026, held at Barcelona.

​The European Association for the Study of the Liver (EASL) Congress is one of the world’s leading international meetings in hepatology, bringing together clinicians, basic scientists, translational researchers, and industry experts to discuss the latest advances in liver biology, liver diseases, and therapeutic innovation. As a premier global platform for academic exchange in hepatology, the congress provides an important opportunity for researchers from diverse disciplines to share new discoveries, explore emerging clinical challenges, and foster international collaboration. During the congress held in Barcelona, Dr. Wenyang Li and Dr. Yihui Gao from the Lei Lab actively engaged with leading scholars and researchers from around the world, participating in discussions on liver disease mechanisms, fibrosis biology, and innovative therapeutic strategies, and exchanging ideas on the group’s ongoing studies in liver fibrosis, extracellular matrix remodeling, and small-molecule-based therapeutic discovery.

The European Association for the Study of the Liver (EASL) Congress is one of the world’s leading international meetings in hepatology, bringing together clinicians, basic scientists, translational researchers, and industry experts to discuss the latest advances in liver biology, liver diseases, and therapeutic innovation. As a premier global platform for academic exchange in hepatology, the congress provides an important opportunity for researchers from diverse disciplines to share new discoveries, explore emerging clinical challenges, and foster international collaboration.

During the congress held in Barcelona, Dr. Wenyang Li and Dr. Yihui Gao from the Lei Lab actively engaged with leading scholars and researchers from around the world, participating in discussions on liver disease mechanisms, fibrosis biology, and innovative therapeutic strategies, and exchanging ideas on the group’s ongoing studies in liver fibrosis, extracellular matrix remodeling, and small-molecule-based therapeutic discovery.